This book is a collection of analyses of methods and practices used to manage OTC derivative counterparty risk and their performance during the 2007-8 financial crisis. It covers the areas of counterparty risk measurement, pricing (CVA), hedging, collateralization, stress testing, back testing and integration into economic capital frameworks. Various new ideas, directions and models are discussed by a group of seasoned experts. The content of the book is even more relevant in light of the recent proposals of the Basel Committee of Banking Supervision for the changes in the regulatory capital on counterparty risks.
The Basel Committee for Banking Supervison (BCBS) has issued a substantive package of changes to the regulatory framework around counterparty credit risks in response to the events of the financial crisis of 2007-8. During this crisis, as in prior, counterparty credit risks have been at the center stage of the most crucial episodes.
Our book examines key aspects of counterparty risk management and models during the crisis and proposes practical guidance to improvements.
It contains a worth of insights useful to practitioners, regulators, consultants, accountants, lawmakers, auditors and researchers to understand the substantive, and often technical, issues on the table.
The book is a collection of clear and concise articles produced by some of the most experienced and prominent professionals in the field. All of them strived to produce material that is substantive and accessible. This provides an invaluable collection of ideas and tools to face the changes and challenges ahead and address some of the most important issues of the moment:
The book consists of 14 chapters broken down into four broad areas:
· Chapters 1 to 5 cover topics related to counterparty risk measurement and management. It focuses on two very current subjects: systemic counterparty risk and collateralization.
· Chapters 6 to 10 cover topics related to the pricing and hedging of counterparty risks and of collateral arrangements. CVAs have caused massive losses to banks during the recent crisis and have motivated some of the recent the Basel Committee’s proposals for reforms of the regulatory capital on counterparty risks. The implications of collateral to OTC derivative valuation, funding costs and availability of funding are important current issues that are covered.
· Chapters 11 and 12 cover stress testing of counterparty risks. The recent experience made clear that stress tests frameworks need to be expanded and enhanced and some new and promising ideas are described.
· Chapters 13 and 14 cover back-testing of counterparty exposure models and the incorporation of counterparty risks into economic and regulatory capital frameworks.
ISBN | 9781906348342 |
---|---|
Navision code | MCPR |
Publication date | 30 Mar 2010 |
Size | 155mm x235mm |
Eduardo Canabarro
Eduardo Canabarro is the Managing Director responsible for Quantitative Risk Management at Morgan Stanley. He is responsible for the development of the methods and models used to measure market and credit risks as well as for the independent review and validation of pricing and risk models used by the bank. Prior to Morgan Stanley, he had a similar position at Lehman Brothers as Managing Director and Global Head of Quantitative Risk Management. Eduardo has also worked for Goldman Sachs and Salomon Brothers in Quantitative Modeling and Risk Management. Eduardo has published various articles in the Journal of Financial Engineering, Journal of Fixed Income, The Journal of Risk Financing, Journal of Risk and Re-Insurance, and RISK. His articles ?Counterparty Risk: Measurement and Pricing’ and ?Analyzing Counterparty Risk’ were cornerstones for the Basel II framework for regulatory capital on counterparty credit risk. He has spoken at leading risk management events around the world including the ones sponsored by the Wharton School, BIS, ICBI, RISK, PRMIA and IAFE. Eduardo holds degrees in Electrical Engineering and MBA (Finance) from UFRGS Brazil as well as MS and PhD degrees in Finance from University of California at Berkeley, USA.
Preface
Section 1: Counterparty risk measurement and management
Ch. 1 Systemic Counterparty Credit Risk – Aaron Brown
Ch. 2 Collateralized Credit Exposure - Michael Pykhtin
Ch. 3 Efficient Derivation of Counterparty Exposure at Default for Trading Book Credit Risk Economic Capital - David Rowe, Dan Travers and Phillip Koop
Ch. 4 Effective Enterprise-wide Collateral Management - Darren Measures
Ch. 5 Evolution of the US Legal Framework for Counterparty Risk Mitigation – Lauren Teigland-Hunt
Section 2: Counterparty risk pricing and hedging
Ch. 6 Pricing and Hedging Counterparty Risk: Lessons Re-Learned? – Eduardo Canabarro
Ch. 7 The Counterparty Risk of Credit Derivative Products – Jon Gregory
Ch. 8 Contingent Credit Default Swaps - Shankar Mukherjee, Andrew Hollings and Svein Stokke
Ch. 9 Funding Benefit and Funding Cost - Yi Tang and Andrew Williams
Ch.10 Generalized Valuation of Collateralized Derivatives - Patrick Chen, Katsuichiro Uchiyama and Guanghua Cao
Section 3: Stress testing of counterparty risk
Ch. 11 Stress Testing and Scenario Analysis: Some Second Generation Approaches - Gregory Hopper
Ch. 12 Computing and Stress Testing Counterparty Credit Risk Capital - Dan Rosen and David Saunders
Section 4: Backtesting and risk capital of counterparty risk
Ch. 13 Back(testing) to the Future: From Market Risk to Counterparty Credit Risk Models - Eduardo Epperlein, Sean Paul Hrabak, Wei Zhu and Alan Smillie
Ch. 14 Economic Capital on Counterparty Risks - Evan Picoult